Oxford Gene Technology launches new Cytocell FISH probes

Oxford Gene Technology has introduced a new set of Cytocell FISH probes for the investigation of glial tumours.

The CE-IVD labelled Cytocell Aquarius 1p36/1q25 and 19q13/19p13 Deletion Probe Kit uses fluorescence in situ hybridisation (FISH) techniques to identify co-deletion of the 1p36.32 and 19q13.33 regions, a trend that is frequently reported in many classes of gliomas.

The presence of a 1p and 19q co-deletion is a strong prognostic factor associated with improved outcomes and responsiveness to therapy, meaning the new kit can play an important role in enhancing treatment outcomes.

It consistently delivers bright, specific signals with minimal background, and provides clear and accurate scoring to reduce the need for repeat testing, saving both time and resources. Ease of use has also been prioritised, providing ready-to-use pre-mixed probes.

Steve Chatters, senior product manager for pathology at Oxford Gene Technology, said: "More laboratories are realising the importance of FISH-based co-deletion analysis for glioma investigations, and our new kit is set to further drive this trend."